That would allow Nubeqa to try to claim market share ... said Bayer's pharma chief Stefan Oelrich. That includes a second phase 3 trial in metastatic hormone-sensitive prostate cancer, ARANOTE ...

Oncology is orphaned One way that pharmaceutical companies have mitigated these risks is to pursue orphan indications for products' initial launches. The Orphan Drug Act of 1983 grants special ...

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.

Spending time in the sun, exercising and eating a seafood-rich diet could drastically cut your risk ... cancer, there is little evidence that supplements alone can help and traditional ...

Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.

CINCINNATI (WKRC) - A new study found a correlation between regular use of a popular over the counter drug and a decreased risk in certain types of cancer. The study, published in the Journal of ...

U.S. Treasury Secretary Scott Bessent in an interview with Yahoo Finance on Tuesday dismissed concerns over China weaponizing its Treasuries despite bond market volatility and added there was no risk ...

Survivors of obesity-related cancers had lower risk for death if they adhered to American Cancer Society guidelines. Maintaining healthy habits before and after diagnosis improved survival ...